Skip to content

Public FDA record

Z-2384-2024: Infusomat SPACE PUMP IV SET , 120 IN.- Used with an electrically-powered infusion pump for intravenous (I

Recall record Z-2384-2024 for B. Braun Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2384-2024
Company in FDA record
B. Braun Medical, Inc.
FDA classification date
Jul 17, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Potential for the backcheck valve to malfunction, resulting in backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime, resulting in patient injuries of adverse drug reaction and/or product malfunction with loss of medication/blood.

Source facts

Action
B. Braun Medical Inc. (BBMI) is issuing a voluntary Urgent Medical Device Correction letter via US Postal Service Certified Mail with registered return receipt on 6/17/24. Letter states reason for recall, health risk and action to take: Corrective actions are being implemented to prevent these concerns in future manufacturing lots through optimization of the disks that provide the sealing function within these valves. Until such time as lots with these corrective actions are available, users are asked to follow the "Interim Measures for Users." A follow-up communication will be provided to users when lots with these corrective actions are in place and the interim measures can be stopped. At this time, we anticipate that corrected sets may become available 04 2024, but more definitive information will be provided in our follow-up notice. Interim Measures for Users: 1. Until further notice, when administering secondary medications via piggyback please clamp the primary line above the upper Y site using the available slide clamp on the pump administration set. This will require unclamping of the primary line after delivery of the secondary medication. The instructions for this differ depending on the type of pump and software as outlined below : a. Attachment 1 provides workflow recommendations for lnfusomat Space Pumps with "U" software versions. b. Attachment 2 provides workflow recommendations for lnfusomat Space Pumps with "G" software versions and "L" (Canada only) software versions. c. Attachment 3 provides workflow recommendations for Outlook ES Pumps. Note: This does not change workflows for rates of infusion greater than 300 ml/hr for lnfusomat Pump Administration Sets and 125 ml/hr with Outlook Pump Administration sets where clamping of the primary infusion line is always required per the product IFU to prevent concurrent flow. 2. Inform all users and post the applicable attachment(s) in care areas where secondary infusions may be administered and where pu
Initiated
2024-06-17
Root cause
Process control
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Recall number
Z-2384-2024
Recall status
Open, Classified
CDRH record ID
208419
FDA classified
2024-07-17
Recall event number
94823

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗